Skip to content

Demonstration dataset: ALL data is used to illustrate platform functionality. The commissioned research programme and final populated platform will focus on MM and MCL.

Launch indications

Multiple Myeloma and Mantle Cell Lymphoma launch overview

5,706
Multiple Myeloma — England registrations in supplied research dataset
617
Mantle Cell Lymphoma — England registrations in supplied research dataset
36,755
Total blood cancers — context denominator only
Current scope
Disease group
Acute lymphoblastic leukaemia (ALL)
Geography
England
Registrations, England
775

Verified market-level registrations for England and its Integrated Care Boards.

National disease registrations provide market context and should not be interpreted as account-level patient volume, MRD testing demand or clonoSEQ utilisation.

Leading England blood-cancer disease groups

Registrations and their share of the 36,755 England blood-cancer registrations (denominator). Multiple Myeloma and Mantle Cell Lymphoma are highlighted.

England blood-cancer registrations by disease group: Myeloma 5,706 · 15.5% registrations; Other blood cancer 5,172 · 14.1% registrations; Diffuse large B-cell lymphoma (DLBCL) and other high grade mature B-cell neoplasms 4,245 · 11.5% registrations; Chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL) 4,074 · 11.1% registrations; Myelodysplastic syndromes (MDS) 2,489 · 6.8% registrations; Acute myeloid leukaemia (AML) 2,463 · 6.7% registrations; Follicular lymphoma 2,411 · 6.6% registrations; Hodgkin lymphoma 1,854 · 5.0% registrations; Essential thrombocythaemia (ET) 1,737 · 4.7% registrations; Mantle cell lymphoma (MCL) 617 · 1.7% registrations

Regional registration distribution

Select an Integrated Care Board to set the geography for this workspace.

Blood-cancer registrations by Integrated Care Board: North East London ICB 812 registrations; Bristol, North Somerset and South Gloucestershire ICB 581 registrations; Black Country ICB 646 registrations

From geography to testing pathway

Move from the national picture into the institutions and the documented MRD pathway.

Account intelligence
  2. Integrated Care Board
    3 boards
    Select a board above